International Point of Care Inc. | Fortis Life Sciences

International Point of Care Incorporated (IPOC), based in Toronto, Canada, is a leading provider of innovative solutions for the in-vitro diagnostic industry and research and development community. With a strong focus on rapid point-of-care testing, we offer contract IVD manufacturing, lateral flow components (including Primecare blood separation membrane), and custom lyophilization services (including lyophilized beaded reagents, LBR) to meet the diverse needs of our global healthcare clientele. Our 36,000 sq ft manufacturing facility is an FDA-registered medical device establishment (cGMP-compliant) and ISO 13485:2016 certified. Our products and services include: • Fine biochemicals (recombinant proteins, monoclonal, and polyclonal antibodies) • Proprietary asymmetric blood separation membranes for application in point-of-care diagnostic tests • Contract lyophilization services to address commercial-scale demand • Contract manufacturing for lateral flow tests including formulation, production assembly, and packaging